Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
Attitudes01:54

Attitudes

Attitude is our evaluation of a person, an idea, or an object. We have attitudes for many things ranging from products that we might pick up in the supermarket to people around the world to political policies. Typically, attitudes are favorable or unfavorable: positive or negative (Eagly & Chaiken, 1993). And, they have three components: an affective component (feelings), a behavioral component (the effect of the attitude on behavior), and a cognitive component (belief and knowledge;...
Antipsychotic Drugs: Typical and Atypical Agents01:21

Antipsychotic Drugs: Typical and Atypical Agents

Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
Antipsychotic Drugs: Therapeutic Uses and Side Effects01:21

Antipsychotic Drugs: Therapeutic Uses and Side Effects

Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The prison reform paradox persists: Rehabilitation capacity, character judgments, and racial resentment predict prison reform attitudes.

Law and human behavior·2026
Same author

Beyond point and level systems: moving toward child-centered programming.

The American journal of orthopsychiatry·2009
Same author

Spirituality, contentment, and stress in recovering alcoholics.

Addictive behaviors·2004
Same author

Associations of sex and type of relationship on intimacy.

Psychological reports·2004
Same author

Accuracy in communication. A contextual approach to child behavior assessment.

Journal of psychosocial nursing and mental health services·2002

Related Experiment Video

Updated: May 21, 2026

Development of a Virtual Reality Assessment of Everyday Living Skills
10:32

Development of a Virtual Reality Assessment of Everyday Living Skills

Published on: April 23, 2014

Attitudes toward psychotropic medications.

Stephanie A Fife1, Kay E Ketzenberger, James N Olson

  • 1Department of Psychology, The University of Texas of the Permian Basin, Odessa 79762, USA.

Psychological Reports
|June 6, 2012
PubMed
Summary

Individuals not using psychotropic medication held more negative views than psychiatric patients. This highlights differing perceptions of psychiatric drugs among various patient groups.

Area of Science:

  • Psychiatry and Psychology
  • Pharmacology
  • Mental Health Research

Background:

  • Psychotropic medications are crucial in managing mental health conditions.
  • Understanding patient attitudes towards these medications is vital for treatment adherence.
  • Substance abuse treatment may influence perceptions of psychiatric drugs.

Purpose of the Study:

  • To compare attitudes and beliefs about psychotropic medication.
  • To assess differences between psychiatric outpatients, buprenorphine-treated patients, and non-users.
  • To identify factors influencing medication perception.

Main Methods:

  • Surveyed 49 participants across three groups: psychiatric outpatients, buprenorphine-treated patients, and non-users.
  • Utilized the Drug Attitude Inventory (DAI) scale.

More Related Videos

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

Related Experiment Videos

Last Updated: May 21, 2026

Development of a Virtual Reality Assessment of Everyday Living Skills
10:32

Development of a Virtual Reality Assessment of Everyday Living Skills

Published on: April 23, 2014

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

  • Employed the Beliefs about Medicines Questionnaire General (BMQ-General).
  • Main Results:

    • Non-users displayed significantly more negative attitudes and beliefs towards psychotropic medication.
    • Psychiatric outpatients and buprenorphine-treated patients showed less negative perceptions compared to non-users.
    • Attitudes varied across the studied groups.

    Conclusions:

    • Beliefs about psychotropic medication differ substantially between users and non-users.
    • Negative attitudes among non-users may present barriers to initiating psychiatric treatment.
    • Further research should explore interventions to address negative medication beliefs.